Biogen BIIB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $319.5M— | $0-100% | $466.5M-26.5% | $634.8M+164% | $240.5M-9.8% | ||
| $204.4M+2.1% | $200.2M-1.0% | $202.2M+4.1% | $194.3M+6.1% | $183.2M-0.4% | ||
| $84M+40.9% | $59.6M-20.8% | $75.3M+0.5% | $74.9M-7.5% | $81M+7.9% | ||
| $645.5M+26.1% | $511.9M-59.8% | $1.27B+691% | $160.9M-37.9% | $259.3M-65.9% | ||
| $51.2M+16.6% | $43.9M-5.0% | $46.2M+73.7% | $26.6M-28.3% | $37.1M-5.6% | ||
| -$209.5M+83.0% | -$1.23B-3,409% | -$35.1M+38.4% | -$57M-20.5% | -$47.3M-154% | ||
| -$43.8M+68.0% | -$137M-5.2% | -$130.2M-1,013% | -$11.7M+49.1% | -$23M— | ||
| $392.2M— | —— | $1.11B+1,101% | $92.2M-51.2% | $189M-74.8% | ||
| $594.3M+27.0% | $468M-61.8% | $1.23B+813% | $134.3M-39.6% | $222.2M-69.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biogen generate?
- Biogen (BIIB) generated $2.6B in operating cash flow over the trailing twelve months.
- What is Biogen's free cash flow?
- After $167.9M of capital expenditures, Biogen's free cash flow was $2.4B over the trailing twelve months, down 0.6% year over year.
- Where does Biogen's cash flow data come from?
- Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
